You are here

GSK, Google parent forge £540m bioelectronic medicines firm

Tie-up will develop miniaturised, implantable devices that can modify electrical nerve signals


GLAXOSMITHKLINE (GSK) and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.The tie-up shows the growing convergence of